The Ras/Rap GTPase activating protein RASA3: From gene structure to invivo functions

Advances in Biological Regulation

Volumn 57, Issue , 2015, Pages 153-161

  Schurmans, Stéphane ^a,b   Polizzi, Séléna ^c   Scoumanne, Ariane ^a,b   Sayyed, Sufyan ^a   Molina Ortiz, Patricia ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Welbio   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cancer; GTPase activating protein; Leukemia; Megakaryocyte; Platelet; Rap; Ras; RASA3

Indexed keywords

MUS; SUIDAE;

CELL RECEPTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; INOSITOL PHOSPHATE; INOSITOL-1,3,4,5-TETRAKISPHOSPHATE; INOSITOL-1,3,4,5-TETRAKISPHOSPHATE RECEPTOR; RASA3 PROTEIN, MOUSE;

ANIMAL; CELL ADHESION; CELL MOTION; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTOPOIESIS; TRANSGENIC MOUSE;

ANIMALS; CELL ADHESION; CELL MOVEMENT; GTPASE-ACTIVATING PROTEINS; HUMANS; INOSITOL PHOSPHATES; MICE; MICE, TRANSGENIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; THROMBOPOIESIS;

EID: 84920784829     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2014.09.006     Document Type: Review

References (41)

1. Baba H., Fuss B., Urano J., Poullet P., Watson J.B., Tamanoi F., et al. GapIII, a new brain-enriched member of the GTPase-activating protein family. JNeurosci Res 1995, 41:846-858.
2. Blanc L., Ciciotte S.L., Gwynn B., Hildick-Smith G.J., Pierce E.L., Soltis K.A., et al. Critical function of the Ras-GTPase activating protein RASA3 in vertebrate erythropoiesis and megakaryopoiesis. Proc Natl Acad Sci U S A 2012, 109:12099-12104.
3. m. Biochem Biophys Res Commun 1998, 250:143-149.
4. Bury L., Malara A., Gresele P., Balduini A. Outside-in signalling generated by a constitutively activated integrin αIIbβ3 impairs proplatelet formation in human megakaryocytes. PLoS One 2012, 7:e34449.
5. Chan J.J., Flatters D., Rodrigues-Lima F., Yan J., Thalassinos K., Katan M. Comparative analysis of interactions of RASSF1-10. Adv Biol Regul 2013, 53:190-201.
6. Chan J.J., Katan M. PLCe{open} and the RASSF family in tumour suppression and other functions. Adv Biol Regul 2013, 53:258-279.
7. Cozier G.E., Lockyer P.J., Reynolds J.S., Kupzig S., Bottomley J.R., Millard T.H., et al. GAP1IP4BP contains a novel group I pleckstrin homology domain that directs constitutive plasma membrane association. JBiol Chem 2000, 275:28261-28268.
8. Cozier G., Sessions R., Bottomley J.R., Reynolds J.S., Cullen P.J. Molecular modelling and site-directed mutagenesis of the inositol 1,3,4,5-tetrakisphosphate-binding pleckstrin homology domain from the Ras GTPase-activating protein GAP1IP4BP. Biochem J 2000, 349:333-342.
9. Cullen P.J., Hsuan J.J., Letcher A.J., Jackson T.R., Dawson A.P., Irvine R.F. Identification of a specific Ins(1,3,4,5)P4-binding protein as a member of the GAP1 family. Nature 1995, 376:527-530.
10. Cullen P.J. Bridging the GAP in inositol 1,3,4,5-tetrakisphosphate signalling. Biochim Biophys Acta 1998, 1436:35-47.
11. Cutts B.A., Sjogren A.K., Andersson K.M., Wahlstrom A.M., Karlsson C., Swolin B., et al. Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice. Blood 2009, 114:3629-3632.
12. Fukuda M., Mikoshiba K. The function of inositol high polyphosphate binding proteins. BioEssay 2006, 19:593-603.
13. Gresele P., Falcinelli E., Giannini S., D'Adamo P., D'Eustacchio A., Corazzi T., et al. Dominant inheritance of a novel integrin β3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. Haematologica 2009, 94:663-669.
14. Gross M., Mkrtchyan H., Glaser M., Fricke H.J., Höffken K., Heller A., et al. Delineation of yet unknown cryptic subtelomere aberrations in 50% of acute myeloid leukemia with normal GTG-banding karyotype. Int J Oncol 2009, 34:417-423.
15. Henkemeyer M., Rossi D.J., Holmyard D.P., Puri M.C., Mbamalu G., Harpal K., et al. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 1995, 377:695-701.
16. Iwashita S., Kobayashi M., Kubo Y., Hinohara Y., Sezaki M., Nakamura K., et al. Versatile roles of R-Ras GAP in neurite formation of PC12 cells and embryonic vascular development. JBiol Chem 2007, 282:3413-3417.
17. 2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proc Natl Acad Sci U S A 2007, 104:12353-12358.
18. Kohlhammer H., Schwaenen C., Wessendorf S., Holzmann K., Kestler H.A., Kienle D., et al. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood 2004, 104:795-801.
19. Kunishima S., Kashiwagi H., Otsu M., Takayama N., Eto K., Onodera M., et al. Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia. Blood 2011, 117:5479-5484.
20. Kupzig S., Deaconescu D., Bouyoucef D., Walker S.A., Liu Q., Polte C.L., et al. GAP1 family members constitute bifunctional Ras and Rap GTPase-activating proteins. JBiol Chem 2006, 281:9891-9900.
21. Liu Q., Walker S.A., Gao D., Taylor J.A., Dai Y.F., Arkell R.S., et al. CAPRI and RASAL impose different modes of information processing on Ras due to contrasting temporal filtering of Ca2+. JCell Biol 2005, 170:183-190.
22. Lockyer P.J., Bottomley J.R., Reynolds J.S., McNulty T.J., Venkateswarlu K., Potter B.V.L., et al. Distinct subcellular localisations of the putative inositol 1,3,4,5-tetrakisphosphate receptors GAP1IP4BP and GAP1m result from the GAP1IP4BP PH domain directing plasma membrane targeting. Curr Biol 1997, 7:1007-1010.
23. m. Biochem Biophys Res Commun 1999, 255:421-426.
24. Lockyer P.J., Kupzig S., Cullen P.J. CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. Curr Biol 2001, 11:981-986.
25. Maertens O., Cichowski K. An expending role for RAS GTPase activating proteins (RAS GAPs) in cancer. Adv Biol Regul 2014, 55:1-14.
26. Maréchal Y., Pesesse X., Jia Y., Pouillon V., Pérez-Morga D., Daniel J., et al. Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells. Proc Natl Acad Sci U S A 2007, 104:13978-13983.
27. McLendon R., Friedman A., Bigner D., Van Meir E.G., Brat D.J., Mastrogianakis G.M., et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
28. m, two inositol 1,3,4,5-tetrakisphosphate-binding proteins. Cell Signal 2001, 13:877-886.
29. Molina-Ortiz P., Polizzi S., Ramery E., Gayral S., Delierneux C., Oury C., et al. Rasa3 controls megakaryocyte Rap1 activation, integrin signaling and differentiation into proplatelet. PLoS Genet 2014, 10:e1004420.
30. Nafisi H., Banihashemi B., Daigle M., Albert P.R. GAP1(IP4BP)/RASA3 mediates Galphai-induced inhibition of mitogen-activated protein kinase. JBiol Chem 2008, 283:35908-35917.
31. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
32. Peters L.L., McFarland-Starr E.C., Wood B.G., Barker J.E. Heritable severe combined anemia and thrombocytopenia in the mouse: description of the disease and successful therapy. Blood 1990, 76:745-754.
33. Portis T., Dyck P., Longnecker R. Epstein-Barr virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. Blood 2008, 102:4166-4178.
34. Slape C., Hartung H., Lin Y.-W., Bies J., Wolff L., Aplan P.D. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation. Cancer Res 2007, 67:5148-5155.
35. Suzuki T., Shen H., Akagi K., Morse H.C., Malley J.D., Naiman D.Q., et al. New genes involved in cancer identified by retroviral tagging. Nat Genet 2002, 32:166-174.
36. Tagawa H., Karnan S., Suzuki R., Matsuo K., Zhang X., Ota A., et al. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 2005, 24:1348-1358.
37. Tang J., Li Y., Lyon K., Camps J., Dalton S., Ried T., et al. Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study wuth colorectal cancer. Oncogene 2014, 33:814-822.
38. Vigil D., Cherfils J., Rosman K.L., Der C.J. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy. Nat Rev Cancer 2010, 10:842-857.
39. 2+ homeostasis. JBiol Chem 2002, 277:48779-48785.
40. Walker S.A., Kupzig S., Bouyoucef D., Davies L.C., Tsubois T., Bivona T.G., et al. Identification of a Ras GTPase-activating protein regulated by receptor-mediated Ca2+ oscillations. EMBO J 2004, 23:1749-1760.
41. Yao R., Yi Y., Grubbs C.J., Lubet R.A., You M. Gene expression profiling of chemically induced rat bladder tumors. Neoplasia 2007, 9:207-221.